Theraputic efficacy of losartan in essential hypertension
Guofu Liu
Abstract
Guofu Liu
Abstract
Objective: To observe the effect of losartan in treating patients with essential hypertension . Methods: Sixty-six patients with essential hypertension were randomized to give losartan 50mg Qd(treatment group) and captopril 12. 5mg Tid(control group)for 6 weeks. The blood Pressure(BP) was measured twice a week and the efficscy was assessed by BP after 6 weeks therapy. Results: The BP was improved more significantly in treatment group than in control group (PO. 05). Conclusions:losartan is an effective and safe antihypertension agent in essential hypertension.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the effect of losartan in treating patients with essential hypertension . Methods: Sixty-six patients with essential hypertension were randomized to give losartan 50mg Qd(treatment group) and captopril 12. 5mg Tid(control group)for 6 weeks. The blood Pressure(BP) was measured twice a week and the efficscy was assessed by BP after 6 weeks therapy. Results: The BP was improved more significantly in treatment group than in control group (PO. 05). Conclusions:losartan is an effective and safe antihypertension agent in essential hypertension.
Key concepts: Losartan, Medicine, Essential hypertension, Captopril, Blood pressure, Internal medicine, Urology, Randomized controlled trial